In the senescence-accelerated mouse prone-8
(SAMP8) mouse, a decline in the expression of Klotho has been
linked to symptoms of AD, including a decline in cognition and an
accumulation of amyloid-b1-42 [223]. Compounds that enhance the
expression of Klotho have been developed as possible therapies for
AD [224].